Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
Department of Haematology, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, China.
Clin Exp Rheumatol. 2021 Sep-Oct;39 Suppl 132(5):129-134. doi: 10.55563/clinexprheumatol/k7ri2l. Epub 2021 Sep 30.
To evaluate the performance of the diagnostic scoring system/criteria for macrophage activation syndrome (MAS) used in systemic juvenile idiopathic arthritis (sJIA) for adult-onset Still's disease (AOSD).
This retrospective case-control study included AOSD patients with and without MAS from six hospitals in China. The cut-off values that best discriminated MAS from active AOSD were determined by receiver operating characteristic (ROC) curve analysis. The performance of the present diagnostic scoring system/criteria for sJIA-MAS was evaluated in AOSD-associated MAS. The optimal critical value of the ROC curve replaces the relevant indicators of the existing scoring system and different models were tested for sensitivity/specificity.
A total of 56 AOSD-associated MAS patients (AOSD-MAS) and 112 AOSD patients without MAS matched with age and sex treated at six centres between 2007 and 2017 were enrolled. The 2016 MAS in sJIA classification criteria had an overall sensitivity of 100.0% and specificity of 80.4% for classifying AOSD-MAS. Excluding hypertriglyceridemia and substituting some other criteria with newly obtained cut-off values could increase specificity. An MS score ≥-2.1 yielded a sensitivity of 95.2% and a specificity of 76.6% in classifying AOSD-MAS. ROC curve analysis revealed that a score of -1.74 could best discriminate AOSD-MAS from AOSD without MAS. An MS score ≥-1.74 yielded a sensitivity of 93.5% and a specificity of 92.6% in diagnosing AOSD-MAS (AUC=0.96, 95%CI: 0.93-0.99, p<0.0001).
The diagnostic tool for MAS in sJIA with modification appears to apply to AOSD-MAS.
评估用于全身型幼年特发性关节炎(sJIA)的巨噬细胞活化综合征(MAS)诊断评分系统/标准在成人Still 病(AOSD)中的表现。
本回顾性病例对照研究纳入了来自中国 6 家医院的伴和不伴 MAS 的 AOSD 患者。通过受试者工作特征(ROC)曲线分析确定最佳区分 MAS 与活动期 AOSD 的截断值。评估 sJIA-MAS 现有诊断评分系统/标准在 AOSD 相关 MAS 中的表现。ROC 曲线的最佳临界值替代现有评分系统的相关指标,并测试不同模型的敏感性/特异性。
共纳入 2007 年至 2017 年在 6 家中心治疗的 56 例 AOSD 相关 MAS 患者(AOSD-MAS)和 112 例年龄和性别相匹配的无 MAS 的 AOSD 患者。2016 年 sJIA 分类标准用于分类 AOSD-MAS 时,总体敏感性为 100.0%,特异性为 80.4%。排除高甘油三酯血症并用新获得的截断值替代其他一些标准可提高特异性。MS 评分≥-2.1 时,用于分类 AOSD-MAS 的敏感性为 95.2%,特异性为 76.6%。ROC 曲线分析显示,评分-1.74 可最佳区分 AOSD-MAS 与无 MAS 的 AOSD。MS 评分≥-1.74 时,用于诊断 AOSD-MAS 的敏感性为 93.5%,特异性为 92.6%(AUC=0.96,95%CI:0.93-0.99,p<0.0001)。
经修正的用于 sJIA 的 MAS 诊断工具似乎适用于 AOSD-MAS。